Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Global research landscape of oligodendrocytes in Alzheimer's disease: A bibliometric and knowledge-mapping analysis from 1990 to 2025.
Identifying Risk Factors for the Rising Prevalence of Multiple Sclerosis in Saudi Arabia: A case-control analysis.
Diabetes-associated MYT1 and ST18 genes regulate human beta cell insulin secretion and survival via other diabetes risk genes.
Contraception Among Women with Selected Autoimmune Diseases in the United States, 2019: A Claims Analysis.
Outcomes of Cardiovascular Surgery in Patients With Multiple Sclerosis.
The degenerome-a novel streamline-wise approach for white matter integrity in neurodegeneration.
Reply to the comment on "efficacy and safety of conventional immunosuppressant therapies in elderly patients with neuromyelitis optica spectrum disorder: A target trial emulation study".
Disease outcomes with ublituximab in treatment-naïve participants: subpopulation analyses of the phase 3 ULTIMATE I and II studies in participants with relapsing multiple sclerosis.
Tumor necrosis factor inhibitor-related autoimmune disorders in pediatric rheumatology practice: a multicenter nationwide study.
Pregnancy outcomes in patients with multiple sclerosis with or without exposure to disease-modifying treatment: A retrospective cohort study on Iranian population.
Aging with multiple sclerosis and associated prevalence, incidence, comorbidities and healthcare utilization patterns in a population based study.
Miller-Fisher Syndrome Presenting With Severe Headache and Transient Loss of Consciousness: A Case Report From Yemen.
COVID-19 Vaccine-triggered Relapsing Immune Dysregulation: An Observational Study with Four-year Follow-up.
Mental health comorbidity and multiple sclerosis outcomes: Clarifying progression through longitudinal, imaging, and equity-focused markers.
Pediatric stroke-like episodes temporally associated with pollen exposure in GJB1-related CMTX1: an expanded family case report with serial MRI and DTI follow-up.
A mathematical model for inflammation and demyelination in multiple sclerosis.
Clinical spectrum and prognostic features of patients seropositive for anti-GD1a antibody.
Infusion-related reactions and premedication patterns in ublituximab-treated multiple sclerosis patients: a multicenter real-world study.
Serum Glial Fibrillary Acidic Protein Dynamics, Disease Progression, and Therapy Response in Multiple Sclerosis.
meningoradiculitis complicating ocrelizumab treatment for multiple sclerosis: A report of three cases.
The gut microbiota plays a modifiable role in MS progression-YES.
Up-Regulation of Anthranilic Acid Formation and Pro-Cognitive Effect of Indoleamine 2,3-Dioxygenase Inhibition.
Response to "On patient-level splitting, contrast-free claims and unsupported comparators in .
Prognostic effect of serum glial fibrillary acidic protein and neurofilament light chain for predicting progression independent of relapse activity in multiple sclerosis: A systematic review.
Stress-reducing activities in multiple sclerosis: Determinants of engagement and associations with 5-year clinical outcomes and quality of life.

Pages